Thiamine and benfotiamine improve cognition and ameliorate GSK-3β-associated stress-induced behaviours in mice.
Thiamine (vitamin B1) deficiency in the brain has been implicated in the development of dementia and symptoms of depression. Indirect evidence suggests that thiamine may contribute to these pathologies by controlling the activities of glycogen synthase kinase (GSK)-3β. While decreased G...
Autori principali: | Markova, N, Bazhenova, N, Anthony, D, Vignisse, J, Svistunov, A, Lesch, K, Bettendorff, L, Strekalova, T |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
Elsevier
2016
|
Documenti analoghi
Documenti analoghi
-
Thiamine and benfotiamine prevent stress-induced suppression of hippocampal neurogenesis in mice exposed to predation without affecting brain thiamine diphosphate levels
di: Vignisse, J, et al.
Pubblicazione: (2017) -
Thiamine and benfotiamine: Focus on their therapeutic potential
di: Iva Bozic, et al.
Pubblicazione: (2023-11-01) -
Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules
di: O. A. Gromova, et al.
Pubblicazione: (2017-07-01) -
Benfotiamine Supplementation Increases Thiamine in Muscle of Endurance-Trained Mice and Affects the Energy Metabolism
di: Álisson C. Gonçalves, et al.
Pubblicazione: (2024-01-01) -
Prostatic acid phosphatase is required for the antinociceptive effects of thiamine and benfotiamine.
di: Julie K Hurt, et al.
Pubblicazione: (2012-01-01)